These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1831542)

  • 21. Cocaine and the cardiovascular system.
    Das G
    Can J Cardiol; 1990 Nov; 6(9):411-5. PubMed ID: 2276079
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cocaine abusers in therapeutic community treatment.
    De Leon G
    NIDA Res Monogr; 1993; 135():163-89. PubMed ID: 8289896
    [No Abstract]   [Full Text] [Related]  

  • 23. Mazindol treatment of cocaine abuse. A double-blind investigation.
    Diakogiannis IA; Steinberg M; Kosten TR
    NIDA Res Monogr; 1990; 105():514. PubMed ID: 1876105
    [No Abstract]   [Full Text] [Related]  

  • 24. Outcome measurement considerations: pharmacological treatments for substance abuse.
    Moras K
    NIDA Res Monogr; 1997; 175():118-36. PubMed ID: 9467795
    [No Abstract]   [Full Text] [Related]  

  • 25. Reply to Dr Peltz.
    Chu LF; Sun J; Clemenson A; Erlendson MJ; Rico T; Cornell E; Obasi H; Sayyid ZN; Encisco EM; Yu J; Gamble JG; Clark JD
    J Addict Med; 2018; 12(3):252-253. PubMed ID: 29794619
    [No Abstract]   [Full Text] [Related]  

  • 26. Efficacy of extended-release tramadol for treatment of prescription opioid withdrawal: a two-phase randomized controlled trial.
    Lofwall MR; Babalonis S; Nuzzo PA; Siegel A; Campbell C; Walsh SL
    Drug Alcohol Depend; 2013 Nov; 133(1):188-97. PubMed ID: 23755929
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Physical dependence potential of daily tramadol dosing in humans.
    Lanier RK; Lofwall MR; Mintzer MZ; Bigelow GE; Strain EC
    Psychopharmacology (Berl); 2010 Sep; 211(4):457-66. PubMed ID: 20589494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Abuse liability, behavioral pharmacology, and physical-dependence potential of opioids in humans and laboratory animals: lessons from tramadol.
    Epstein DH; Preston KL; Jasinski DR
    Biol Psychol; 2006 Jul; 73(1):90-9. PubMed ID: 16497429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The non-antiemetic uses of serotonin 5-HT3 receptor antagonists. Clinical pharmacology and therapeutic applications.
    Greenshaw AJ; Silverstone PH
    Drugs; 1997 Jan; 53(1):20-39. PubMed ID: 9010647
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse.
    Hagan RM; Kilpatrick GJ; Tyers MB
    Psychopharmacology (Berl); 1993; 112(1 Suppl):S68-75. PubMed ID: 7831443
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the 5HT3 antagonist ondansetron (O) for cocaine (C)-like activity and abuse potential.
    Jasinski DR; Preston KL; Testa M; Sullivan JT
    NIDA Res Monogr; 1990; 105():515. PubMed ID: 1831542
    [No Abstract]   [Full Text] [Related]  

  • 32. The pharmacology of cocaine related to its abuse.
    Johanson CE; Fischman MW
    Pharmacol Rev; 1989 Mar; 41(1):3-52. PubMed ID: 2682679
    [No Abstract]   [Full Text] [Related]  

  • 33. Prediction in drug abuse: cocaine interactions with alcohol and buprenorphine.
    Mannelli P; Janiri L; Tempesta E; Jones RT
    Br J Psychiatry Suppl; 1993 Sep; (21):39-45. PubMed ID: 8217067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Psychological issues in the treatment of cocaine abuse.
    Resnick RB; Resnick E
    NIDA Res Monogr; 1986; 67():290-4. PubMed ID: 3092080
    [No Abstract]   [Full Text] [Related]  

  • 35. Cognitive-neuromotor assessment of substance abuse: focus on issues related to cocaine abuse treatment.
    Ellinwood EH; Lee TH
    NIDA Res Monogr; 1997; 175():192-207. PubMed ID: 9467799
    [No Abstract]   [Full Text] [Related]  

  • 36.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.